Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects.
Objectives: Polymyxin B is a last-line antibiotic for multidrug-resistant gram-negative bacterial infections. However, limited safety and pharmacokinetic information is available. We investigated the safety and pharmacokinetics of intravenous polymyxin B in healthy subjects.Methods: An open-label, s...
| Published in: | Journal of Infection Vol. 82; no. 2; pp. 207 - 216 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | research randomized controlled trial Journal Article |
| Published: |
W B Saunders
Feb2021
|
| Online Access: | View this record in EBSCOhost |